Projects funded by the NCN
Novel dual CYP17A1 and AKR1C3 inhibitors for studying the mechanism of resistance in prostate cancer
2020/39/D/NZ7/00572
Keywords:
prostate cancer medicinal chemistry enzyme inhibition
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Medyczny w Lublinie
woj. lubelskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 4
Call: SONATA 16 - announced on 2020-09-15
Amount awarded: 695 400 PLN
Project start date (Y-m-d): 2021-10-01
Project end date (Y-m-d): 2024-09-30
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.